X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/21/2850096/30505/en/MediWound-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Company-Update.html
https://www.globenewswire.com//news-release/2024/03/14/2846241/30505/en/MediWound-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/12/2827407/30505/en/MediWound-Announces-Positive-Results-in-Head-to-Head-Comparison-of-EscharEx-vs-SANTYL-within-the-ChronEx-Phase-II-Randomized-Controlled-Study.html
https://www.globenewswire.com//news-release/2024/02/05/2823453/30505/en/MediWound-to-Participate-in-Two-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/01/09/2806137/30505/en/MediWound-Announces-that-FDA-has-Accepted-for-Review-the-Supplement-to-the-NexoBrid-BLA-to-Include-Pediatric-Patients-with-Severe-Thermal-Burns.html
https://www.globenewswire.com//news-release/2023/12/21/2799949/30505/en/MediWound-Announces-Peer-Reviewed-Publication-of-EscharEx-Mechanism-of-Action-Study-Assessing-Its-Effects-on-Biofilm-and-Microbial-Loads.html
https://www.globenewswire.com//news-release/2023/11/21/2783933/30505/en/MediWound-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Company-Update.html
https://www.globenewswire.com//news-release/2023/11/21/2783924/30505/en/MediWound-Announces-Appointment-of-Shmulik-Hess-Ph-D-as-Chief-Operating-Officer-and-Chief-Commercial-Officer.html
https://www.globenewswire.com//news-release/2023/11/14/2780053/30505/en/MediWound-to-Report-Third-Quarter-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2023/11/08/2776066/30505/en/MediWound-Announces-a-Collaboration-with-PolyMedics-Innovations-PMI-for-NexoBrid-Distribution-in-Europe.html
Market Place
Share 
